Drug Registration and Acceptance

Drug Name

Exact

Active Ingredient

Acceptance No.

Manufacturers

Acceptance Date

Status Date

Classification

Review Status

Drug Type

Submission

Evaluation Conclusion

ATC Category

Special Approval Varieties

Task Type

Major Special Varieties

Sequence No.

Stock Code

Visualized Analysis Export Evaluation Conclusion Evaluation Progress

Acceptance No.	Drug Name	Active Ingredient	Dosage Form	Classification	Submission	Acceptance Date	Manufacturers	Manufacturers	Review Status	Status Date	View
CYHL2101034	丙酸氟替卡松吸入粉雾剂	fluticasone propionate	Powder for inhalation	Chemical Drugs(3)	Generic Drug	2021-11-05		Respirent Pharmaceuticals Co Ltd			view
CYHL2101020	丙酸氟替卡松吸入粉雾剂	fluticasone propionate	Powder for inhalation	Chemical Drugs(3)	Generic Drug	2021-08-09		Respirent Pharmaceuticals Co Ltd			view
CYHL2100013	丙酸氟替卡松吸入粉雾剂	fluticasone propionate	Powder for inhalation	Chemical Drugs(3)	Generic Drug	2021-02-24	润生药业有限公司	Respirent Pharmaceuticals Co Ltd	In Review	2021-02-23	view
CYHS2401133	丙酸氟替卡松吸入粉雾剂	fluticasone propionate	Powder for inhalation	Chemical Drugs(3)	Generic Drug	2024-04-17		Respirent Pharmaceuticals Co Ltd			view
JYHZ0700052	丙酸氟替卡松粉雾剂	fluticasone propionate	Powder for inhalation	Chemical Drugs	License Renew	2007-05-08	Glaxo Wellcome UK Limited	Glaxo Wellcome Operations	Certificate Issued	2008-01-25	view
JYHB0901020	丙酸氟替卡松粉雾剂	fluticasone propionate	Powder for inhalation	Chemical Drugs	Supplementary Application	2009-11-27	葛兰素史克（中国）投资有限公司	GlaxoSmithKline (China) Investment Co Ltd	Certificate Issued	2013-04-18	view